Q2 2025 Management View Michael F. Mahoney, Chairman, President & CEO, emphasized, "Our second quarter results outperformed ...

The company now expects a tariff charge of $100 million this year, down from a $200 million impact forecast on the company’s ...

In stocks, Nvidia more than 1% rose as investors await Alphabet GOOGL earnings at market close. Shares also rose following a ...

According to the Market Basket Board of Directors, both Schmidt and Gordon were fired for making false and derogatory remarks ...

The latest so-called meme stocks include doughnut maker Krispy Kreme, camera maker GoPro and plant-based meat maker Beyond Meat. Each company is surging Wednesday, even though overall they have been ...

Boston Scientific bumped up its financial forecasts for the remainder of this year, after reporting double-digit growth ...

Sales of previously occupied U.S. homes slid in June to the slowest pace since last September as mortgage rates remained ...

U.S. stocks are rising toward another record following a trade deal between the world’s No. 1 and No. 4 economies.

If the Boston Red Sox are truly entertaining trade offers for Jarren Duran, the Padres, Phillies and Mets are contenders who could go all-in.

Boston Scientific expects 2025 adjusted profit of $2.95 to $2.99 per share, up from the prior view of $2.87 to $2.94 earlier.

Boston Scientific (NYSE: BSX) shares ticked up before hours today on second-quarter results that came in ahead of the consensus forecast.

For the third quarter, the stent maker forecast earnings in a range between 44 cents and 46 cents a share on sales growth of about 17%-to-19%. On an adjusted basis, Boston Sci targeted earnings ...